SlideShare a Scribd company logo
1 of 6
Download to read offline
_____________________________________________________________________________________________________
*Corresponding author: Email: paul_greenberg@brown.edu;
British Journal of Medicine & Medical Research
10(5): 1-6, 2015, Article no.BJMMR.19640
ISSN: 2231-0614
SCIENCEDOMAIN international
www.sciencedomain.org
Financial Disclosures in Academic Publications and
the Sunshine Act: A Concordance Study
Claudine Yee1,2
, Paul B. Greenberg1,2*
, Curtis E. Margo3
and Dustin D. French4
1
Section of Ophthalmology, Providence VA Medical Center, Providence, Rhode Island, USA.
2
Division of Ophthalmology, Warren Alpert Medical School of Brown University, Providence,
Rhode Island, USA.
3
Departments of Pathology and Cell Biology, Ophthalmology, Morsani College of Medicine, University
of South Florida, Tampa, Florida, USA.
4
Center for Healthcare Studies, Department of Ophthalmology, Northwestern University, Feinberg
School of Medicine, Department of Veterans Affairs, Health Services Research and
Development, Chicago, Illinois, USA.
Authors’ contributions
This work was carried out in collaboration between all authors. Authors PBG and CEM designed the
study. All authors collected and analyzed data. Author CY drafted the manuscript. All authors revised
the manuscript and approved the final version.
Article Information
DOI: 10.9734/BJMMR/2015/19640
Editor(s):
(1) Pradeep Venkatesh, Professor, Ophthalmology, All India Institute of Medical Sciences, New Delhi,
India.
Reviewers:
(1) Sheldon Krimsky, Urban & Environmental Policy & Planning, Tufts University, USA.
(2) Camila Brasil Moreira, Federal University of Ceara, Brazil.
Complete Peer review History: http://sciencedomain.org/review-history/10595
Received 21
st
June 2015
Accepted 1st
August 2015
Published 19
th
August 2015
ABSTRACT
Aims: To assess the concordance between conflicts of interest reported by physicians in three
major scientific journals and industry-reported payments available through the Open Payments
Program (OPP) database.
Study Design: Comparative cross-sectional surveys.
Place and Duration of Study: United States allopathic and osteopathic physicians with
publications in American Journal of Ophthalmology, JAMA Ophthalmology, and Ophthalmology
accepted after January 1, 2014 and published from May 2014 through October 2014.
Methodology: We compared physicians’ self-reported conflicts of interest in their academic
publications to industry-reported payments in the Centers for Medicare & Medicaid Services OPP
Original Research Article
Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640
2
database. Authors were categorized based on concordance between self-reported disclosures and
payments listed in the database. Payments were designated as disclosed or undisclosed.
Results: Of the 670 authors surveyed, 367 (54.8%) were in perfect concordance with the OPP
database; 68 (10.1%) authors made disclosures beyond those in the database but had no
undisclosed ties; 235 (35.1%) authors had one or more undisclosed payments. Disclosed and
undisclosed payments totaled $1.46 million and $1.81 million, respectively.
Conclusion: In three major ophthalmology journals, a significant discrepancy exists between
conflicts of interest reported by physician authors and payments found in the OPP database. This
lack of concordance raises concerns about incomplete physician disclosure, inaccurate reporting,
inadequate vetting, and ambiguity over financial relevance, all of which undermine confidence in
the disclosure process.
Keywords: Conflict of interest; sunshine act; financial disclosure; transparency.
1. INTRODUCTION
The Centers for Medicare & Medicaid Services
(CMS) released the Open Payments Program
(OPP) database with the intent of increasing
transparency of financial relationships between
physicians and industry [1]. Released in
fulfillment of the Physician Payments Sunshine
Act initiative of the Affordable Care Act, the OPP
database publically reports payments to United
States-licensed physicians by manufacturers of
federally covered drugs, devices, biological, or
medical supplies. Individual payments less than
$10.00 are exempt, unless the annual aggregate
exceeds $100.00. The database has been
criticized for being difficult to use, not thoroughly
vetted, and incomplete [2]; nevertheless it
contains information that may shape opinion
about conflict of interest (COI) in research and
medicine.
Accurate COI reporting is essential to the
integrity of scientific research as well as trust in
the physician-patient relationship. Currently,
most peer-reviewed scientific journals rely on
authors to self-report COI. As the OPP database
shows payments made by manufacturers to
physicians, it offers the opportunity to evaluate
the accuracy of financial disclosures. This study
examined the agreement between physician-
reported COI in three major ophthalmology
journals and payments recorded in the OPP
database.
2. METHODOLOGY
The OPP data we analyzed included payments
made between August 1 and December 31,
2013. Thus one inclusion criterion for journal
manuscripts was an acceptance date on or after
January 1, 2014, which ensures that payments
would have transpired during the time of the
work. Our review of OPP data also occurred
subsequent to the December 2014 update, which
included any previously disputed claims.
Original scientific studies or editorials accepted
for publication after January 1, 2014 and
published between May and October 2014 from
American Journal of Ophthalmology, JAMA
Ophthalmology, and Ophthalmology were
included in our study. American allopathic and
osteopathic physician authors from these papers
were the subjects of our survey. We performed a
Google search in situations where MD/OD status
was ambiguous. A single reviewer abstracted
each paper for qualified physicians, self-reported
financial disclosures and conflicts of interest,
including sources. We then searched the
General, Research, and Ownership databases
on the OPP website by physician name and
verified by Physician Profile ID for financial
payments to each author during the study period
[3]. Information about the amount, source, nature
of the payment, and whether it was contested,
were collected; payments within the same
category and manufacturer were summed and
considered as one payment. Physicians who
authored multiple papers were counted as new
authors with each original paper since each
study offered the potential for different financial
disclosures. To confirm completeness and
accuracy of data collection, we selected a third of
the papers for independent second review by
three co-authors. We then compared payments
in the database to self-reported conflicts of
interest and categorized the payments as
disclosed or undisclosed. Authors were
categorized based on concordance between self-
reported financial disclosures and payments
listed in the database. We analyzed results
collectively for the three journals using
descriptive statistics.
Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640
3
3. RESULTS
There were 493 original papers and editorials
published during the 6-month study period that
met inclusion criteria. These articles had 670
American physician authors; 260 (38.8%) had
payments listed in the OPP databases, and 146
(21.8%) had self-reported financial disclosures.
Only one author had contested payments.
Concordance status for all 670 authors is
reported in Table 1. The 367 (54.8%) authors
that had complete agreement between self-
reported financial disclosures and payments in
the OPP database are listed as concordant.
Another 68 (10.1%) authors reported financial
disclosures that were not in the database but had
no undisclosed payments. The remaining 235
(35.1%) authors had at least one undisclosed
payment in the database.
Of the 146 authors who reported COI, only 2 had
perfect agreement between self-reported
financial disclosures and payments listed in the
database. The 2 authors with perfect agreement
along with 365 additional authors who did not
report financial disclosures and had no payments
listed in the database are listed in Table 1 as
concordant.
Another 23 (3.4% of total) authors reported all
relationships listed in the database and additional
relationships not in the database. Forty-five
authors disclosed COI but had no payments
recorded in OPP. These two groups (68 [10.1%]
authors) are listed in Table 1 as non-concordant
with excess self-reporting. There were 235
authors who made disclosures that either did not
match reports or under reported records in the
OPP database. This group is listed in the non-
concordant under reporting section of Table 1.
One hundred fifty-nine authors in this category
(23.7% of total) reported no financial disclosures
but had payments listed in the database. The
remaining 76 authors reported COI but had one
or more discrepancies when compared to
payments listed in the database.
Table 2 contains payment distribution information
from the OPP database during the six-month
study period. Disclosed payments and
undisclosed payments totaled $1.46 million and
$1.81 million, respectively. Payments fell into 13
categories, with the most number of payments in
the Food and Beverage category (560 summed
payments) and the highest value in Research
($1.21 million). For every category, the number
of undisclosed payments was greater than the
number disclosed; the amount of undisclosed
payments was also greater for all categories
except Research.
Table 1. Concordance between self-reported financial disclosures and industry-reported
payments in the Open Payments Program (OPP) database
Agreement category Number of
authors (%)
Concordance
No self-reported financial disclosures and no payments listed in OPP database 365 (54.5)
Perfect agreement between self-reported financial disclosures and payments listed in
OPP database
2 (0.3)
Total 367 (54.8)
Non-concordance with excess self-reporting
Self-reported financial disclosures but no disclosures listed in OPP database 45 (6.7)
Self-reported financial disclosures in agreement with payments listed in OPP database
AND self-reported disclosures in excess of payments listed in OPP database
23 (3.4)
Total 68 (10.1)
Non-concordance with under self-reporting*
No self-reported financial disclosures but payments listed in OPP database 159 (23.7)
Self-reported financial disclosures not in agreement with payments listed in OPP
database AND self-reported disclosures in excess of payments listed in OPP database
37 (5.5)
Some self-reported financial disclosures in agreement but fewer than payments listed in
OPP database AND self-reported disclosures in excess of those listed in database
30 (4.5)
Some self-reported financial disclosures in agreement but fewer than disclosures listed
in OPP database
9 (1.3)
Total 235 (35.1)
Total 670 (100)
*Authors with both excess and under-reporting were listed in the under-reporting category
Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640
4
4. DISCUSSION
Our survey of COI statements from three major
US eye journals from May through October 2014
showed a lack of concordance between authors’
acknowledged COI and their financial payments
in the OPP database. One hundred fifty-nine
(23.7%) authors with payments listed in the
database reported no financial disclosures. Only
10.4% of the authors surveyed fully disclosed
their financial reimbursements in their
publications (i.e., perfect agreement plus those
with agreement and excess self-reporting).
Undisclosed payments during this 6-month
period exceeded disclosed payments by
$350,000.
Contrary to some opinions that the CMS website
is difficult to use [2,4], we found the search
engine workable and information easily
extractable. The difficulty arises in distinguishing
what type and amount of payment differentiates
worrisome from trivial interactions [5]. The CMS
describes the dilemma this way: “Sharing
information about financial relationships alone is
not enough to decide whether they’re beneficial
or improper” [6].
Payments in the OPP database fell into 13
categories (Table 2). However, the limited
contextual framework for the individual financial
payments makes details about particular
commercial relationships largely speculative.
This shortcoming is important as the amount of
money industry bestows to ophthalmologists is
not inconsequential: during the last five months
of 2013 (after the OPP made records available),
ophthalmologists received just under $11 million
with 42% ($4.6 million) for consulting work [4].
Problems with vetting the OPP database have
been raised, including a backlog of disputed
records [2]. Delays in the vetting process,
however, would result in payments being listed
as “disputed.” Although we encountered just one
disputed claim, it is possible other physicians
may have considered the effort to contest a claim
too burdensome to pursue. In addition, we came
across several cases where physician specialty
was mislabeled for different payments to the
same physician. Regardless, physicians will bear
the burden of dissonant reports due in large part
because their names are listed on a public
website as having had a financial interaction with
industry.
Further complicating the discussion of
transparency are observations that the Sunshine
Act contains loopholes such as exemptions from
reporting rebates given to physicians as
incentives to use expensive drugs and the
“unrestricted grants” provided by industry for
accredited continuing medical education [5].
Besides certain loopholes, it is possible that legal
ambiguities surrounding the definition of an OPP-
delineated industry could have kept some
businesses from reporting financial relationships.
Table 2. Distribution of disclosed and undisclosed payments to authors
Category Number of
payments
Total
payments ($)
Disclosed
payments
Disclosed
amount ($)
Undisclosed
payments
Undisclosed
amount ($)
Compensation for
services other than
consulting
44 222,365. 20 83,912. 24 138,453.
Compensation for
serving as faculty or
speaker for CME
program
18 49,287. 5 12,700. 13 36,587.
Consulting Fee 143 1,059,450. 55 472,278. 88 587,172.
Education 73 77,835. 14 24,269. 59 53,566.
Entertainment 13 657. 3 109. 10 547.
Food and Beverage 560 87,102. 107 23,037. 453 64,065.
Gift 26 11,626. 6 4,673. 20 6,953.
Grant 1 1,000. 0 0 1 1,000.
Honoraria 7 9,958. 1 1,000. 6 8,958.
Ownership 2 179,250. 0 0 2 179,250.
Research 19 1,209,001. 7 663,648. 12 545,353.
Royalty or License 8 129,075. 6 98,136. 2 30,939.
Travel and Lodging 116 235,429. 39 80,923. 77 154,506.
Totals 1,030 3,272,036. 263 1,464,686. 767 1,807,350.
Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640
5
Another consideration when evaluating
discrepant results is ambiguous financial
disclosure statements. The International
Committee of Medical Journal Editors (ICMJE)
disclosure form, which is used by the three
journals evaluated herein, requests “relevant
financial activities” be divulged [7]. The form
defines “relevant” as activities “that could be
perceived to influence, or that give the
appearance of potentially influencing, what you
wrote in the submitted work.” [7]. The ICMJE
form does request disclosures not specially
related to a submitted work for 36 months prior to
submission, but that too is couched in the term
relevant. The money or gifts physicians receive
from industry may seem to have no relevant
relationship to the research they perform, but
patients and physicians have been shown to
have differing perspectives on what constitutes
an unacceptable financial tie [8,9].
There are limitations of this study. One is the
relatively brief sample period of 6 months, which
provides only a snapshot of the concordance
between authors’ acknowledged COI and their
financial payments in the OPP database.
Another is that authors from these three journals
may not be representative of authors who publish
in other eye journals, particularly those with less
clinical orientation. Finally, it is possible that
authors whose disclosures were not listed in
OPP were reporting activities that pre-dated the
government-mandated reporting date.
5. CONCLUSION
This study suggests that the laudable goals of
financial transparency in medical research and
clinical practice are confounded by a lack of
concordance in self-reported COI and payments
recorded in the OPP database. This lack of
concordance could be due to incomplete
disclosures by physicians, inaccurate reporting,
inadequate vetting, or ambiguity over what is
financially relevant. Unless some means of
distinguishing beneficial financial interactions
from conflicts of interest exist, medical editors
may recommend that authors confirm the
accuracy of self-reported financial disclosures
against those found in the OPP database before
papers are published, or fully disclose all industry
payments regardless of perceived relevance [10].
CONSENT
This study was granted exemption by the
Providence Veterans Affairs Medical Center
Institutional Review Board.
ETHICAL APPROVAL
All authors hereby declare that all experiments
have been examined and granted an exemption
by the Providence Veterans Affairs Medical
Center Institutional Review Board and have been
performed in accordance with the ethical
standards laid down in the 1964 Declaration of
Helsinki.
ACKNOWLEDGEMENTS
This material is the result of work supported with
resources and the use of facilities at the
Providence VA Medical Center, Providence,
Rhode Island, USA. The views expressed in this
article are those of the authors and do not
necessarily reflect the position or policy of the
Department of Veterans Affairs or the United
States government.
COMPETING INTERESTS
Authors have declared that no competing
interests exist.
REFERENCES
1. Agrawal S, Brenman N, Budetti P. The
Sunshine Act: Effects on physicians. N
Engl J Med. 2013;368: 2054-7.
2. Santhakumar S, Adashi EY. The Physician
Payment Sunshine Act: Testing the value
of transparency. JAMA. 2015;313(1):23-4.
DOI:10.1001/jama.2014.15472
3. Centers for Medicare and Medicaid
Services. Data Explorer. Accessed 21 April
2015.
Available:https://openpaymentsdata.cms.g
ov/browse
4. Chang JS. The physician payments
sunshine act: Data evaluation regarding
payments to ophthalmologists. Ophthalmo-
logy. 2015;122(4): 656-61.
DOI: 10.1016/j.ophtha.2014.11.003.
5. Lichter PR. Implications of the Sunshine
Act – revelations, loopholes, and impact.
Ophthalmology. 2015;122(4):653-5.
Available:http://dx.doi.org/11.1016/j.ophtha
.2014.12.020
6. Centers for Medicare & Medicaid Services.
Open Payments Data in Context.
Accessed 21 April 2015.
Available:http://www.cms.gov/OpenPayme
nts/About/Open-Payments-Data-in-
Context.html
Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640
6
7. International Committee of Medical Journal
Editors. Conflicts of Interest.
Available: http://www.icmje.org/conflicts-of-
interest/
8. Licurse A, Barber E, Joffe S, Gross C. The
impact of disclosing financial ties in
research and clinical care: A systematic
review. Arch Intern Med. 2010;10(8):675-
82.
9. Dana J, Loewenstein G. A social science
perspective on gifts to physicians from
industry. JAMA. 2003;290(2):252-255.
DOI:10.1001/jama.290.2.252.
10. Liesegang TJ, Bartley GB. Toward
transparency of financial disclosure.
Ophthalmology. 2014;121(11):2077-8.
© 2015 Yee et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.
Peer-review history:
The peer review history for this paper can be accessed here:
http://sciencedomain.org/review-history/10595

More Related Content

What's hot

Kaufman_et_al-2015-The_Journal_of_Rural_Health
Kaufman_et_al-2015-The_Journal_of_Rural_HealthKaufman_et_al-2015-The_Journal_of_Rural_Health
Kaufman_et_al-2015-The_Journal_of_Rural_HealthBrystana Kaufman
 
Hospital treated pneumonia - Diagnosis and Treatment
Hospital treated pneumonia - Diagnosis and TreatmentHospital treated pneumonia - Diagnosis and Treatment
Hospital treated pneumonia - Diagnosis and TreatmentBostonsp
 
Hospital Treated Sepsis - Treatment
Hospital Treated Sepsis - Treatment Hospital Treated Sepsis - Treatment
Hospital Treated Sepsis - Treatment Bostonsp
 
HEA 409 - Expensive U.S. Health Care - DESALVA
HEA 409 - Expensive U.S. Health Care - DESALVAHEA 409 - Expensive U.S. Health Care - DESALVA
HEA 409 - Expensive U.S. Health Care - DESALVAJulie DeSalva
 
Hospital treated pneumonia - Diagnosis
Hospital treated pneumonia - DiagnosisHospital treated pneumonia - Diagnosis
Hospital treated pneumonia - DiagnosisBostonsp
 
Medicare Delivery System Reform
Medicare Delivery System Reform Medicare Delivery System Reform
Medicare Delivery System Reform KFF
 
Research aarkstoreenterprise disease and therapy review non small cell lung...
Research aarkstoreenterprise   disease and therapy review non small cell lung...Research aarkstoreenterprise   disease and therapy review non small cell lung...
Research aarkstoreenterprise disease and therapy review non small cell lung...Neel Terde
 
Healthcare Fraud: Illegal Kickback Schemes in Medicare & Medicaid
Healthcare Fraud: Illegal Kickback Schemes in Medicare & MedicaidHealthcare Fraud: Illegal Kickback Schemes in Medicare & Medicaid
Healthcare Fraud: Illegal Kickback Schemes in Medicare & Medicaidlawsuitlegal
 
Hit-Miss Model for Duplicate Detection-WHO Drug Safety Database_PVER Conf_May...
Hit-Miss Model for Duplicate Detection-WHO Drug Safety Database_PVER Conf_May...Hit-Miss Model for Duplicate Detection-WHO Drug Safety Database_PVER Conf_May...
Hit-Miss Model for Duplicate Detection-WHO Drug Safety Database_PVER Conf_May...NORC at the University of Chicago
 
Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.Paul Coelho, MD
 
Provenance-Centered Dataset of Drug-Drug Interactions
Provenance-Centered Dataset of Drug-Drug InteractionsProvenance-Centered Dataset of Drug-Drug Interactions
Provenance-Centered Dataset of Drug-Drug Interactionsjmbanda
 
How Machine Learning Can Detect Medicare Fraud
How Machine Learning Can Detect Medicare FraudHow Machine Learning Can Detect Medicare Fraud
How Machine Learning Can Detect Medicare Fraudvenkatvajradhar1
 
No 2 getting started with selecting a database page 1
No 2 getting started with selecting a database page 1No 2 getting started with selecting a database page 1
No 2 getting started with selecting a database page 1Alison Day
 
Research aarkstoreenterprise disease and therapy review multiple sclerosis
Research aarkstoreenterprise   disease and therapy review  multiple sclerosisResearch aarkstoreenterprise   disease and therapy review  multiple sclerosis
Research aarkstoreenterprise disease and therapy review multiple sclerosisNeel Terde
 
Fundamentals of Health Insurance Big Data Management: Master Patient Index De...
Fundamentals of Health Insurance Big Data Management: Master Patient Index De...Fundamentals of Health Insurance Big Data Management: Master Patient Index De...
Fundamentals of Health Insurance Big Data Management: Master Patient Index De...Salus One Ed
 

What's hot (19)

Kaufman_et_al-2015-The_Journal_of_Rural_Health
Kaufman_et_al-2015-The_Journal_of_Rural_HealthKaufman_et_al-2015-The_Journal_of_Rural_Health
Kaufman_et_al-2015-The_Journal_of_Rural_Health
 
Hospital treated pneumonia - Diagnosis and Treatment
Hospital treated pneumonia - Diagnosis and TreatmentHospital treated pneumonia - Diagnosis and Treatment
Hospital treated pneumonia - Diagnosis and Treatment
 
Hospital Treated Sepsis - Treatment
Hospital Treated Sepsis - Treatment Hospital Treated Sepsis - Treatment
Hospital Treated Sepsis - Treatment
 
HEA 409 - Expensive U.S. Health Care - DESALVA
HEA 409 - Expensive U.S. Health Care - DESALVAHEA 409 - Expensive U.S. Health Care - DESALVA
HEA 409 - Expensive U.S. Health Care - DESALVA
 
Hospital treated pneumonia - Diagnosis
Hospital treated pneumonia - DiagnosisHospital treated pneumonia - Diagnosis
Hospital treated pneumonia - Diagnosis
 
Medicare Delivery System Reform
Medicare Delivery System Reform Medicare Delivery System Reform
Medicare Delivery System Reform
 
Research aarkstoreenterprise disease and therapy review non small cell lung...
Research aarkstoreenterprise   disease and therapy review non small cell lung...Research aarkstoreenterprise   disease and therapy review non small cell lung...
Research aarkstoreenterprise disease and therapy review non small cell lung...
 
Directed Project
Directed ProjectDirected Project
Directed Project
 
my paper
my papermy paper
my paper
 
R Bays - HHS Releases Physician-level Medicare Data
R Bays - HHS Releases Physician-level Medicare DataR Bays - HHS Releases Physician-level Medicare Data
R Bays - HHS Releases Physician-level Medicare Data
 
Project 9 Poster SRF
Project 9 Poster SRFProject 9 Poster SRF
Project 9 Poster SRF
 
Healthcare Fraud: Illegal Kickback Schemes in Medicare & Medicaid
Healthcare Fraud: Illegal Kickback Schemes in Medicare & MedicaidHealthcare Fraud: Illegal Kickback Schemes in Medicare & Medicaid
Healthcare Fraud: Illegal Kickback Schemes in Medicare & Medicaid
 
Hit-Miss Model for Duplicate Detection-WHO Drug Safety Database_PVER Conf_May...
Hit-Miss Model for Duplicate Detection-WHO Drug Safety Database_PVER Conf_May...Hit-Miss Model for Duplicate Detection-WHO Drug Safety Database_PVER Conf_May...
Hit-Miss Model for Duplicate Detection-WHO Drug Safety Database_PVER Conf_May...
 
Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.
 
Provenance-Centered Dataset of Drug-Drug Interactions
Provenance-Centered Dataset of Drug-Drug InteractionsProvenance-Centered Dataset of Drug-Drug Interactions
Provenance-Centered Dataset of Drug-Drug Interactions
 
How Machine Learning Can Detect Medicare Fraud
How Machine Learning Can Detect Medicare FraudHow Machine Learning Can Detect Medicare Fraud
How Machine Learning Can Detect Medicare Fraud
 
No 2 getting started with selecting a database page 1
No 2 getting started with selecting a database page 1No 2 getting started with selecting a database page 1
No 2 getting started with selecting a database page 1
 
Research aarkstoreenterprise disease and therapy review multiple sclerosis
Research aarkstoreenterprise   disease and therapy review  multiple sclerosisResearch aarkstoreenterprise   disease and therapy review  multiple sclerosis
Research aarkstoreenterprise disease and therapy review multiple sclerosis
 
Fundamentals of Health Insurance Big Data Management: Master Patient Index De...
Fundamentals of Health Insurance Big Data Management: Master Patient Index De...Fundamentals of Health Insurance Big Data Management: Master Patient Index De...
Fundamentals of Health Insurance Big Data Management: Master Patient Index De...
 

Viewers also liked

2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical ResearchMarket iT
 
11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_sante11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_santeMarket iT
 
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...Market iT
 
Jeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & TransparenceJeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & TransparenceMarket iT
 
Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015Market iT
 
FDA Medical Device Guidance
FDA Medical Device GuidanceFDA Medical Device Guidance
FDA Medical Device GuidanceMarket iT
 
Le Leem interpelle les pouvoirs publics sur des nouveaux mécanismes de régula...
Le Leem interpelle les pouvoirs publics sur des nouveaux mécanismes de régula...Le Leem interpelle les pouvoirs publics sur des nouveaux mécanismes de régula...
Le Leem interpelle les pouvoirs publics sur des nouveaux mécanismes de régula...Market iT
 
HAS : Référentiel de bonnes pratiques sur les applications et les objets conn...
HAS : Référentiel de bonnes pratiques sur les applications et les objets conn...HAS : Référentiel de bonnes pratiques sur les applications et les objets conn...
HAS : Référentiel de bonnes pratiques sur les applications et les objets conn...Market iT
 
What’s new in Pharmacovigilance
What’s new in PharmacovigilanceWhat’s new in Pharmacovigilance
What’s new in PharmacovigilanceMarket iT
 
Joe 20161230 0303_0064
Joe 20161230 0303_0064Joe 20161230 0303_0064
Joe 20161230 0303_0064Market iT
 
Programme 10ème universite afcdp des CIL
Programme 10ème universite afcdp des CILProgramme 10ème universite afcdp des CIL
Programme 10ème universite afcdp des CILMarket iT
 
Jeudi 24 mars 2016 | Etudes non interventionnelles : respecter les contraint...
Jeudi 24 mars 2016 | Etudes non interventionnelles :  respecter les contraint...Jeudi 24 mars 2016 | Etudes non interventionnelles :  respecter les contraint...
Jeudi 24 mars 2016 | Etudes non interventionnelles : respecter les contraint...Market iT
 
Rapport codeem 2015
Rapport codeem 2015Rapport codeem 2015
Rapport codeem 2015Market iT
 
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...Market iT
 
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PC
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PCLe FBI autorisé par la Cour Suprême à pirater n'importe quel PC
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PCMarket iT
 
3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharma3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharmaMarket iT
 
The Medicines Australia Code of Conduct
The Medicines Australia Code of ConductThe Medicines Australia Code of Conduct
The Medicines Australia Code of ConductMarket iT
 
Colombia transparency resolution draft
Colombia transparency resolution draftColombia transparency resolution draft
Colombia transparency resolution draftMarket iT
 
Global Transparency Reporting Congress
Global Transparency Reporting CongressGlobal Transparency Reporting Congress
Global Transparency Reporting CongressMarket iT
 
Eshlsg consultation-results-october2013
Eshlsg consultation-results-october2013Eshlsg consultation-results-october2013
Eshlsg consultation-results-october2013Market iT
 

Viewers also liked (20)

2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical Research
 
11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_sante11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_sante
 
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
 
Jeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & TransparenceJeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & Transparence
 
Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015
 
FDA Medical Device Guidance
FDA Medical Device GuidanceFDA Medical Device Guidance
FDA Medical Device Guidance
 
Le Leem interpelle les pouvoirs publics sur des nouveaux mécanismes de régula...
Le Leem interpelle les pouvoirs publics sur des nouveaux mécanismes de régula...Le Leem interpelle les pouvoirs publics sur des nouveaux mécanismes de régula...
Le Leem interpelle les pouvoirs publics sur des nouveaux mécanismes de régula...
 
HAS : Référentiel de bonnes pratiques sur les applications et les objets conn...
HAS : Référentiel de bonnes pratiques sur les applications et les objets conn...HAS : Référentiel de bonnes pratiques sur les applications et les objets conn...
HAS : Référentiel de bonnes pratiques sur les applications et les objets conn...
 
What’s new in Pharmacovigilance
What’s new in PharmacovigilanceWhat’s new in Pharmacovigilance
What’s new in Pharmacovigilance
 
Joe 20161230 0303_0064
Joe 20161230 0303_0064Joe 20161230 0303_0064
Joe 20161230 0303_0064
 
Programme 10ème universite afcdp des CIL
Programme 10ème universite afcdp des CILProgramme 10ème universite afcdp des CIL
Programme 10ème universite afcdp des CIL
 
Jeudi 24 mars 2016 | Etudes non interventionnelles : respecter les contraint...
Jeudi 24 mars 2016 | Etudes non interventionnelles :  respecter les contraint...Jeudi 24 mars 2016 | Etudes non interventionnelles :  respecter les contraint...
Jeudi 24 mars 2016 | Etudes non interventionnelles : respecter les contraint...
 
Rapport codeem 2015
Rapport codeem 2015Rapport codeem 2015
Rapport codeem 2015
 
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
 
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PC
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PCLe FBI autorisé par la Cour Suprême à pirater n'importe quel PC
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PC
 
3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharma3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharma
 
The Medicines Australia Code of Conduct
The Medicines Australia Code of ConductThe Medicines Australia Code of Conduct
The Medicines Australia Code of Conduct
 
Colombia transparency resolution draft
Colombia transparency resolution draftColombia transparency resolution draft
Colombia transparency resolution draft
 
Global Transparency Reporting Congress
Global Transparency Reporting CongressGlobal Transparency Reporting Congress
Global Transparency Reporting Congress
 
Eshlsg consultation-results-october2013
Eshlsg consultation-results-october2013Eshlsg consultation-results-october2013
Eshlsg consultation-results-october2013
 

Similar to Financial Disclosures in Academic Publications and the Sunshine Act: A Concordance Study

Intro_bea_health_care_satellite_account
Intro_bea_health_care_satellite_accountIntro_bea_health_care_satellite_account
Intro_bea_health_care_satellite_accountBryn Whitmire
 
IOM-Conflict-of-Interest-Disclosure
IOM-Conflict-of-Interest-DisclosureIOM-Conflict-of-Interest-Disclosure
IOM-Conflict-of-Interest-DisclosureSusan Chimonas
 
A 58-year-old man needs to have his blood tested on a regular basis .docx
A 58-year-old man needs to have his blood tested on a regular basis .docxA 58-year-old man needs to have his blood tested on a regular basis .docx
A 58-year-old man needs to have his blood tested on a regular basis .docxjosephinepaterson7611
 
Addressing Social Isolation To Improve the Health of.pdf
Addressing Social Isolation To Improve the Health of.pdfAddressing Social Isolation To Improve the Health of.pdf
Addressing Social Isolation To Improve the Health of.pdfFULYAENAYAVCI
 
Topic Position paper on Proposition 8Number of Pages 1 (Dou.docx
Topic Position paper on Proposition 8Number of Pages 1 (Dou.docxTopic Position paper on Proposition 8Number of Pages 1 (Dou.docx
Topic Position paper on Proposition 8Number of Pages 1 (Dou.docxAASTHA76
 
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...ijtsrd
 
American Medical Home Runs (1)
American Medical Home Runs (1)American Medical Home Runs (1)
American Medical Home Runs (1)Jeffrey Kang
 
Meaningfulcareorg txhima6-30-13-130925145004-phpapp02
Meaningfulcareorg txhima6-30-13-130925145004-phpapp02Meaningfulcareorg txhima6-30-13-130925145004-phpapp02
Meaningfulcareorg txhima6-30-13-130925145004-phpapp02Carla Pitcher
 
Medicare healthcare charge disparity analysis
Medicare healthcare charge disparity analysisMedicare healthcare charge disparity analysis
Medicare healthcare charge disparity analysisGopalakrishna Palem
 
Discussion for Week 4SubscribeTopic  Explain the data i.docx
Discussion for Week 4SubscribeTopic  Explain the data i.docxDiscussion for Week 4SubscribeTopic  Explain the data i.docx
Discussion for Week 4SubscribeTopic  Explain the data i.docxmadlynplamondon
 
The impacts of lifestyle behavior on
The impacts of lifestyle behavior onThe impacts of lifestyle behavior on
The impacts of lifestyle behavior onhiij
 
Accounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docxAccounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docxnettletondevon
 
Dr Dev Kambhampati | Medicare- High Expenditure Part B Drugs
Dr Dev Kambhampati | Medicare- High Expenditure Part B DrugsDr Dev Kambhampati | Medicare- High Expenditure Part B Drugs
Dr Dev Kambhampati | Medicare- High Expenditure Part B DrugsDr Dev Kambhampati
 
Remedy SNF Performance Network White Paper 2_2016 (Footnoted)
Remedy SNF Performance Network White Paper 2_2016 (Footnoted)Remedy SNF Performance Network White Paper 2_2016 (Footnoted)
Remedy SNF Performance Network White Paper 2_2016 (Footnoted)Catherine Olexa
 
Cost-Savings Study: Analysis of Health Management Options
Cost-Savings Study: Analysis of Health Management OptionsCost-Savings Study: Analysis of Health Management Options
Cost-Savings Study: Analysis of Health Management OptionsYour Health at Hand
 
Hospital Pricing Issues Cost Employers Money
Hospital Pricing Issues Cost Employers MoneyHospital Pricing Issues Cost Employers Money
Hospital Pricing Issues Cost Employers MoneyMark Gall
 
Phase 1 - Research Data CollectionName Points.docx
Phase 1 - Research Data CollectionName Points.docxPhase 1 - Research Data CollectionName Points.docx
Phase 1 - Research Data CollectionName Points.docxkarlhennesey
 
Health Information Technology Continues to Show Positive Effect on
Health Information Technology Continues to Show Positive Effect onHealth Information Technology Continues to Show Positive Effect on
Health Information Technology Continues to Show Positive Effect onJeanmarieColbert3
 
BRM-Final report Income’s Effect On Expenditure
BRM-Final report Income’s Effect On ExpenditureBRM-Final report Income’s Effect On Expenditure
BRM-Final report Income’s Effect On ExpenditureEssam Imtiaz
 
Advance health assessment and Pharmacology.docx
Advance health assessment and Pharmacology.docxAdvance health assessment and Pharmacology.docx
Advance health assessment and Pharmacology.docxwrite22
 

Similar to Financial Disclosures in Academic Publications and the Sunshine Act: A Concordance Study (20)

Intro_bea_health_care_satellite_account
Intro_bea_health_care_satellite_accountIntro_bea_health_care_satellite_account
Intro_bea_health_care_satellite_account
 
IOM-Conflict-of-Interest-Disclosure
IOM-Conflict-of-Interest-DisclosureIOM-Conflict-of-Interest-Disclosure
IOM-Conflict-of-Interest-Disclosure
 
A 58-year-old man needs to have his blood tested on a regular basis .docx
A 58-year-old man needs to have his blood tested on a regular basis .docxA 58-year-old man needs to have his blood tested on a regular basis .docx
A 58-year-old man needs to have his blood tested on a regular basis .docx
 
Addressing Social Isolation To Improve the Health of.pdf
Addressing Social Isolation To Improve the Health of.pdfAddressing Social Isolation To Improve the Health of.pdf
Addressing Social Isolation To Improve the Health of.pdf
 
Topic Position paper on Proposition 8Number of Pages 1 (Dou.docx
Topic Position paper on Proposition 8Number of Pages 1 (Dou.docxTopic Position paper on Proposition 8Number of Pages 1 (Dou.docx
Topic Position paper on Proposition 8Number of Pages 1 (Dou.docx
 
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
 
American Medical Home Runs (1)
American Medical Home Runs (1)American Medical Home Runs (1)
American Medical Home Runs (1)
 
Meaningfulcareorg txhima6-30-13-130925145004-phpapp02
Meaningfulcareorg txhima6-30-13-130925145004-phpapp02Meaningfulcareorg txhima6-30-13-130925145004-phpapp02
Meaningfulcareorg txhima6-30-13-130925145004-phpapp02
 
Medicare healthcare charge disparity analysis
Medicare healthcare charge disparity analysisMedicare healthcare charge disparity analysis
Medicare healthcare charge disparity analysis
 
Discussion for Week 4SubscribeTopic  Explain the data i.docx
Discussion for Week 4SubscribeTopic  Explain the data i.docxDiscussion for Week 4SubscribeTopic  Explain the data i.docx
Discussion for Week 4SubscribeTopic  Explain the data i.docx
 
The impacts of lifestyle behavior on
The impacts of lifestyle behavior onThe impacts of lifestyle behavior on
The impacts of lifestyle behavior on
 
Accounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docxAccounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docx
 
Dr Dev Kambhampati | Medicare- High Expenditure Part B Drugs
Dr Dev Kambhampati | Medicare- High Expenditure Part B DrugsDr Dev Kambhampati | Medicare- High Expenditure Part B Drugs
Dr Dev Kambhampati | Medicare- High Expenditure Part B Drugs
 
Remedy SNF Performance Network White Paper 2_2016 (Footnoted)
Remedy SNF Performance Network White Paper 2_2016 (Footnoted)Remedy SNF Performance Network White Paper 2_2016 (Footnoted)
Remedy SNF Performance Network White Paper 2_2016 (Footnoted)
 
Cost-Savings Study: Analysis of Health Management Options
Cost-Savings Study: Analysis of Health Management OptionsCost-Savings Study: Analysis of Health Management Options
Cost-Savings Study: Analysis of Health Management Options
 
Hospital Pricing Issues Cost Employers Money
Hospital Pricing Issues Cost Employers MoneyHospital Pricing Issues Cost Employers Money
Hospital Pricing Issues Cost Employers Money
 
Phase 1 - Research Data CollectionName Points.docx
Phase 1 - Research Data CollectionName Points.docxPhase 1 - Research Data CollectionName Points.docx
Phase 1 - Research Data CollectionName Points.docx
 
Health Information Technology Continues to Show Positive Effect on
Health Information Technology Continues to Show Positive Effect onHealth Information Technology Continues to Show Positive Effect on
Health Information Technology Continues to Show Positive Effect on
 
BRM-Final report Income’s Effect On Expenditure
BRM-Final report Income’s Effect On ExpenditureBRM-Final report Income’s Effect On Expenditure
BRM-Final report Income’s Effect On Expenditure
 
Advance health assessment and Pharmacology.docx
Advance health assessment and Pharmacology.docxAdvance health assessment and Pharmacology.docx
Advance health assessment and Pharmacology.docx
 

More from Market iT

LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...
LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...
LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...Market iT
 
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...Market iT
 
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...Market iT
 
Loi sapin II
Loi sapin IILoi sapin II
Loi sapin IIMarket iT
 
Guide lanceur d'alerte
Guide lanceur d'alerteGuide lanceur d'alerte
Guide lanceur d'alerteMarket iT
 
TRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislationTRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislationMarket iT
 
SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017Market iT
 
Transparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerteTransparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerteMarket iT
 
Espace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_lineEspace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_lineMarket iT
 
Guidelines on consent under GDPR
Guidelines on consent under GDPRGuidelines on consent under GDPR
Guidelines on consent under GDPRMarket iT
 
MedTech europe code of ethical business practice
MedTech europe code of ethical business practiceMedTech europe code of ethical business practice
MedTech europe code of ethical business practiceMarket iT
 
Un logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médicalUn logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médicalMarket iT
 
Le canard enchainé 2017.11.08 - des labos soignant l'éthique
Le canard enchainé   2017.11.08 - des labos soignant l'éthiqueLe canard enchainé   2017.11.08 - des labos soignant l'éthique
Le canard enchainé 2017.11.08 - des labos soignant l'éthiqueMarket iT
 
analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)Market iT
 
Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox Market iT
 
Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018Market iT
 
Cybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicauxCybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicauxMarket iT
 
HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016Market iT
 
Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016Market iT
 
Codeem rapport d'activité 2016
Codeem rapport d'activité 2016Codeem rapport d'activité 2016
Codeem rapport d'activité 2016Market iT
 

More from Market iT (20)

LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...
LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...
LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...
 
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
 
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
 
Loi sapin II
Loi sapin IILoi sapin II
Loi sapin II
 
Guide lanceur d'alerte
Guide lanceur d'alerteGuide lanceur d'alerte
Guide lanceur d'alerte
 
TRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislationTRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislation
 
SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017
 
Transparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerteTransparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerte
 
Espace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_lineEspace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_line
 
Guidelines on consent under GDPR
Guidelines on consent under GDPRGuidelines on consent under GDPR
Guidelines on consent under GDPR
 
MedTech europe code of ethical business practice
MedTech europe code of ethical business practiceMedTech europe code of ethical business practice
MedTech europe code of ethical business practice
 
Un logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médicalUn logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médical
 
Le canard enchainé 2017.11.08 - des labos soignant l'éthique
Le canard enchainé   2017.11.08 - des labos soignant l'éthiqueLe canard enchainé   2017.11.08 - des labos soignant l'éthique
Le canard enchainé 2017.11.08 - des labos soignant l'éthique
 
analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)
 
Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox
 
Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018
 
Cybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicauxCybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicaux
 
HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016
 
Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016
 
Codeem rapport d'activité 2016
Codeem rapport d'activité 2016Codeem rapport d'activité 2016
Codeem rapport d'activité 2016
 

Recently uploaded

VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Call Girls in Nagpur High Profile
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Low Rate Call Girls Patna Anika 8250192130 Independent Escort Service Patna
Low Rate Call Girls Patna Anika 8250192130 Independent Escort Service PatnaLow Rate Call Girls Patna Anika 8250192130 Independent Escort Service Patna
Low Rate Call Girls Patna Anika 8250192130 Independent Escort Service Patnamakika9823
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...astropune
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiAlinaDevecerski
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls ServiceMiss joya
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Deliverynehamumbai
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...indiancallgirl4rent
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Miss joya
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...Neha Kaur
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...narwatsonia7
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Miss joya
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...Miss joya
 

Recently uploaded (20)

VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 
Low Rate Call Girls Patna Anika 8250192130 Independent Escort Service Patna
Low Rate Call Girls Patna Anika 8250192130 Independent Escort Service PatnaLow Rate Call Girls Patna Anika 8250192130 Independent Escort Service Patna
Low Rate Call Girls Patna Anika 8250192130 Independent Escort Service Patna
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
 

Financial Disclosures in Academic Publications and the Sunshine Act: A Concordance Study

  • 1. _____________________________________________________________________________________________________ *Corresponding author: Email: paul_greenberg@brown.edu; British Journal of Medicine & Medical Research 10(5): 1-6, 2015, Article no.BJMMR.19640 ISSN: 2231-0614 SCIENCEDOMAIN international www.sciencedomain.org Financial Disclosures in Academic Publications and the Sunshine Act: A Concordance Study Claudine Yee1,2 , Paul B. Greenberg1,2* , Curtis E. Margo3 and Dustin D. French4 1 Section of Ophthalmology, Providence VA Medical Center, Providence, Rhode Island, USA. 2 Division of Ophthalmology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA. 3 Departments of Pathology and Cell Biology, Ophthalmology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. 4 Center for Healthcare Studies, Department of Ophthalmology, Northwestern University, Feinberg School of Medicine, Department of Veterans Affairs, Health Services Research and Development, Chicago, Illinois, USA. Authors’ contributions This work was carried out in collaboration between all authors. Authors PBG and CEM designed the study. All authors collected and analyzed data. Author CY drafted the manuscript. All authors revised the manuscript and approved the final version. Article Information DOI: 10.9734/BJMMR/2015/19640 Editor(s): (1) Pradeep Venkatesh, Professor, Ophthalmology, All India Institute of Medical Sciences, New Delhi, India. Reviewers: (1) Sheldon Krimsky, Urban & Environmental Policy & Planning, Tufts University, USA. (2) Camila Brasil Moreira, Federal University of Ceara, Brazil. Complete Peer review History: http://sciencedomain.org/review-history/10595 Received 21 st June 2015 Accepted 1st August 2015 Published 19 th August 2015 ABSTRACT Aims: To assess the concordance between conflicts of interest reported by physicians in three major scientific journals and industry-reported payments available through the Open Payments Program (OPP) database. Study Design: Comparative cross-sectional surveys. Place and Duration of Study: United States allopathic and osteopathic physicians with publications in American Journal of Ophthalmology, JAMA Ophthalmology, and Ophthalmology accepted after January 1, 2014 and published from May 2014 through October 2014. Methodology: We compared physicians’ self-reported conflicts of interest in their academic publications to industry-reported payments in the Centers for Medicare & Medicaid Services OPP Original Research Article
  • 2. Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640 2 database. Authors were categorized based on concordance between self-reported disclosures and payments listed in the database. Payments were designated as disclosed or undisclosed. Results: Of the 670 authors surveyed, 367 (54.8%) were in perfect concordance with the OPP database; 68 (10.1%) authors made disclosures beyond those in the database but had no undisclosed ties; 235 (35.1%) authors had one or more undisclosed payments. Disclosed and undisclosed payments totaled $1.46 million and $1.81 million, respectively. Conclusion: In three major ophthalmology journals, a significant discrepancy exists between conflicts of interest reported by physician authors and payments found in the OPP database. This lack of concordance raises concerns about incomplete physician disclosure, inaccurate reporting, inadequate vetting, and ambiguity over financial relevance, all of which undermine confidence in the disclosure process. Keywords: Conflict of interest; sunshine act; financial disclosure; transparency. 1. INTRODUCTION The Centers for Medicare & Medicaid Services (CMS) released the Open Payments Program (OPP) database with the intent of increasing transparency of financial relationships between physicians and industry [1]. Released in fulfillment of the Physician Payments Sunshine Act initiative of the Affordable Care Act, the OPP database publically reports payments to United States-licensed physicians by manufacturers of federally covered drugs, devices, biological, or medical supplies. Individual payments less than $10.00 are exempt, unless the annual aggregate exceeds $100.00. The database has been criticized for being difficult to use, not thoroughly vetted, and incomplete [2]; nevertheless it contains information that may shape opinion about conflict of interest (COI) in research and medicine. Accurate COI reporting is essential to the integrity of scientific research as well as trust in the physician-patient relationship. Currently, most peer-reviewed scientific journals rely on authors to self-report COI. As the OPP database shows payments made by manufacturers to physicians, it offers the opportunity to evaluate the accuracy of financial disclosures. This study examined the agreement between physician- reported COI in three major ophthalmology journals and payments recorded in the OPP database. 2. METHODOLOGY The OPP data we analyzed included payments made between August 1 and December 31, 2013. Thus one inclusion criterion for journal manuscripts was an acceptance date on or after January 1, 2014, which ensures that payments would have transpired during the time of the work. Our review of OPP data also occurred subsequent to the December 2014 update, which included any previously disputed claims. Original scientific studies or editorials accepted for publication after January 1, 2014 and published between May and October 2014 from American Journal of Ophthalmology, JAMA Ophthalmology, and Ophthalmology were included in our study. American allopathic and osteopathic physician authors from these papers were the subjects of our survey. We performed a Google search in situations where MD/OD status was ambiguous. A single reviewer abstracted each paper for qualified physicians, self-reported financial disclosures and conflicts of interest, including sources. We then searched the General, Research, and Ownership databases on the OPP website by physician name and verified by Physician Profile ID for financial payments to each author during the study period [3]. Information about the amount, source, nature of the payment, and whether it was contested, were collected; payments within the same category and manufacturer were summed and considered as one payment. Physicians who authored multiple papers were counted as new authors with each original paper since each study offered the potential for different financial disclosures. To confirm completeness and accuracy of data collection, we selected a third of the papers for independent second review by three co-authors. We then compared payments in the database to self-reported conflicts of interest and categorized the payments as disclosed or undisclosed. Authors were categorized based on concordance between self- reported financial disclosures and payments listed in the database. We analyzed results collectively for the three journals using descriptive statistics.
  • 3. Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640 3 3. RESULTS There were 493 original papers and editorials published during the 6-month study period that met inclusion criteria. These articles had 670 American physician authors; 260 (38.8%) had payments listed in the OPP databases, and 146 (21.8%) had self-reported financial disclosures. Only one author had contested payments. Concordance status for all 670 authors is reported in Table 1. The 367 (54.8%) authors that had complete agreement between self- reported financial disclosures and payments in the OPP database are listed as concordant. Another 68 (10.1%) authors reported financial disclosures that were not in the database but had no undisclosed payments. The remaining 235 (35.1%) authors had at least one undisclosed payment in the database. Of the 146 authors who reported COI, only 2 had perfect agreement between self-reported financial disclosures and payments listed in the database. The 2 authors with perfect agreement along with 365 additional authors who did not report financial disclosures and had no payments listed in the database are listed in Table 1 as concordant. Another 23 (3.4% of total) authors reported all relationships listed in the database and additional relationships not in the database. Forty-five authors disclosed COI but had no payments recorded in OPP. These two groups (68 [10.1%] authors) are listed in Table 1 as non-concordant with excess self-reporting. There were 235 authors who made disclosures that either did not match reports or under reported records in the OPP database. This group is listed in the non- concordant under reporting section of Table 1. One hundred fifty-nine authors in this category (23.7% of total) reported no financial disclosures but had payments listed in the database. The remaining 76 authors reported COI but had one or more discrepancies when compared to payments listed in the database. Table 2 contains payment distribution information from the OPP database during the six-month study period. Disclosed payments and undisclosed payments totaled $1.46 million and $1.81 million, respectively. Payments fell into 13 categories, with the most number of payments in the Food and Beverage category (560 summed payments) and the highest value in Research ($1.21 million). For every category, the number of undisclosed payments was greater than the number disclosed; the amount of undisclosed payments was also greater for all categories except Research. Table 1. Concordance between self-reported financial disclosures and industry-reported payments in the Open Payments Program (OPP) database Agreement category Number of authors (%) Concordance No self-reported financial disclosures and no payments listed in OPP database 365 (54.5) Perfect agreement between self-reported financial disclosures and payments listed in OPP database 2 (0.3) Total 367 (54.8) Non-concordance with excess self-reporting Self-reported financial disclosures but no disclosures listed in OPP database 45 (6.7) Self-reported financial disclosures in agreement with payments listed in OPP database AND self-reported disclosures in excess of payments listed in OPP database 23 (3.4) Total 68 (10.1) Non-concordance with under self-reporting* No self-reported financial disclosures but payments listed in OPP database 159 (23.7) Self-reported financial disclosures not in agreement with payments listed in OPP database AND self-reported disclosures in excess of payments listed in OPP database 37 (5.5) Some self-reported financial disclosures in agreement but fewer than payments listed in OPP database AND self-reported disclosures in excess of those listed in database 30 (4.5) Some self-reported financial disclosures in agreement but fewer than disclosures listed in OPP database 9 (1.3) Total 235 (35.1) Total 670 (100) *Authors with both excess and under-reporting were listed in the under-reporting category
  • 4. Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640 4 4. DISCUSSION Our survey of COI statements from three major US eye journals from May through October 2014 showed a lack of concordance between authors’ acknowledged COI and their financial payments in the OPP database. One hundred fifty-nine (23.7%) authors with payments listed in the database reported no financial disclosures. Only 10.4% of the authors surveyed fully disclosed their financial reimbursements in their publications (i.e., perfect agreement plus those with agreement and excess self-reporting). Undisclosed payments during this 6-month period exceeded disclosed payments by $350,000. Contrary to some opinions that the CMS website is difficult to use [2,4], we found the search engine workable and information easily extractable. The difficulty arises in distinguishing what type and amount of payment differentiates worrisome from trivial interactions [5]. The CMS describes the dilemma this way: “Sharing information about financial relationships alone is not enough to decide whether they’re beneficial or improper” [6]. Payments in the OPP database fell into 13 categories (Table 2). However, the limited contextual framework for the individual financial payments makes details about particular commercial relationships largely speculative. This shortcoming is important as the amount of money industry bestows to ophthalmologists is not inconsequential: during the last five months of 2013 (after the OPP made records available), ophthalmologists received just under $11 million with 42% ($4.6 million) for consulting work [4]. Problems with vetting the OPP database have been raised, including a backlog of disputed records [2]. Delays in the vetting process, however, would result in payments being listed as “disputed.” Although we encountered just one disputed claim, it is possible other physicians may have considered the effort to contest a claim too burdensome to pursue. In addition, we came across several cases where physician specialty was mislabeled for different payments to the same physician. Regardless, physicians will bear the burden of dissonant reports due in large part because their names are listed on a public website as having had a financial interaction with industry. Further complicating the discussion of transparency are observations that the Sunshine Act contains loopholes such as exemptions from reporting rebates given to physicians as incentives to use expensive drugs and the “unrestricted grants” provided by industry for accredited continuing medical education [5]. Besides certain loopholes, it is possible that legal ambiguities surrounding the definition of an OPP- delineated industry could have kept some businesses from reporting financial relationships. Table 2. Distribution of disclosed and undisclosed payments to authors Category Number of payments Total payments ($) Disclosed payments Disclosed amount ($) Undisclosed payments Undisclosed amount ($) Compensation for services other than consulting 44 222,365. 20 83,912. 24 138,453. Compensation for serving as faculty or speaker for CME program 18 49,287. 5 12,700. 13 36,587. Consulting Fee 143 1,059,450. 55 472,278. 88 587,172. Education 73 77,835. 14 24,269. 59 53,566. Entertainment 13 657. 3 109. 10 547. Food and Beverage 560 87,102. 107 23,037. 453 64,065. Gift 26 11,626. 6 4,673. 20 6,953. Grant 1 1,000. 0 0 1 1,000. Honoraria 7 9,958. 1 1,000. 6 8,958. Ownership 2 179,250. 0 0 2 179,250. Research 19 1,209,001. 7 663,648. 12 545,353. Royalty or License 8 129,075. 6 98,136. 2 30,939. Travel and Lodging 116 235,429. 39 80,923. 77 154,506. Totals 1,030 3,272,036. 263 1,464,686. 767 1,807,350.
  • 5. Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640 5 Another consideration when evaluating discrepant results is ambiguous financial disclosure statements. The International Committee of Medical Journal Editors (ICMJE) disclosure form, which is used by the three journals evaluated herein, requests “relevant financial activities” be divulged [7]. The form defines “relevant” as activities “that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work.” [7]. The ICMJE form does request disclosures not specially related to a submitted work for 36 months prior to submission, but that too is couched in the term relevant. The money or gifts physicians receive from industry may seem to have no relevant relationship to the research they perform, but patients and physicians have been shown to have differing perspectives on what constitutes an unacceptable financial tie [8,9]. There are limitations of this study. One is the relatively brief sample period of 6 months, which provides only a snapshot of the concordance between authors’ acknowledged COI and their financial payments in the OPP database. Another is that authors from these three journals may not be representative of authors who publish in other eye journals, particularly those with less clinical orientation. Finally, it is possible that authors whose disclosures were not listed in OPP were reporting activities that pre-dated the government-mandated reporting date. 5. CONCLUSION This study suggests that the laudable goals of financial transparency in medical research and clinical practice are confounded by a lack of concordance in self-reported COI and payments recorded in the OPP database. This lack of concordance could be due to incomplete disclosures by physicians, inaccurate reporting, inadequate vetting, or ambiguity over what is financially relevant. Unless some means of distinguishing beneficial financial interactions from conflicts of interest exist, medical editors may recommend that authors confirm the accuracy of self-reported financial disclosures against those found in the OPP database before papers are published, or fully disclose all industry payments regardless of perceived relevance [10]. CONSENT This study was granted exemption by the Providence Veterans Affairs Medical Center Institutional Review Board. ETHICAL APPROVAL All authors hereby declare that all experiments have been examined and granted an exemption by the Providence Veterans Affairs Medical Center Institutional Review Board and have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. ACKNOWLEDGEMENTS This material is the result of work supported with resources and the use of facilities at the Providence VA Medical Center, Providence, Rhode Island, USA. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. COMPETING INTERESTS Authors have declared that no competing interests exist. REFERENCES 1. Agrawal S, Brenman N, Budetti P. The Sunshine Act: Effects on physicians. N Engl J Med. 2013;368: 2054-7. 2. Santhakumar S, Adashi EY. The Physician Payment Sunshine Act: Testing the value of transparency. JAMA. 2015;313(1):23-4. DOI:10.1001/jama.2014.15472 3. Centers for Medicare and Medicaid Services. Data Explorer. Accessed 21 April 2015. Available:https://openpaymentsdata.cms.g ov/browse 4. Chang JS. The physician payments sunshine act: Data evaluation regarding payments to ophthalmologists. Ophthalmo- logy. 2015;122(4): 656-61. DOI: 10.1016/j.ophtha.2014.11.003. 5. Lichter PR. Implications of the Sunshine Act – revelations, loopholes, and impact. Ophthalmology. 2015;122(4):653-5. Available:http://dx.doi.org/11.1016/j.ophtha .2014.12.020 6. Centers for Medicare & Medicaid Services. Open Payments Data in Context. Accessed 21 April 2015. Available:http://www.cms.gov/OpenPayme nts/About/Open-Payments-Data-in- Context.html
  • 6. Yee et al.; BJMMR, 10(5): 1-6, 2015; Article no.BJMMR.19640 6 7. International Committee of Medical Journal Editors. Conflicts of Interest. Available: http://www.icmje.org/conflicts-of- interest/ 8. Licurse A, Barber E, Joffe S, Gross C. The impact of disclosing financial ties in research and clinical care: A systematic review. Arch Intern Med. 2010;10(8):675- 82. 9. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290(2):252-255. DOI:10.1001/jama.290.2.252. 10. Liesegang TJ, Bartley GB. Toward transparency of financial disclosure. Ophthalmology. 2014;121(11):2077-8. © 2015 Yee et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Peer-review history: The peer review history for this paper can be accessed here: http://sciencedomain.org/review-history/10595